Nektar Therapeutics (NKTR) Announces $175M Common Stock Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/18/2024
- Wall St opens higher as some chip stocks bounce back after selloff
- Taiwan Semi (TSM) Q1 profit beats expectations on AI demand
- European stocks edge higher as dollar eases, oil prices fall
- Dollar rally stalls after rare FX warning from finance chiefs
- Oil extends losses on easing Middle East tension, demand concerns
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- ICZOOM Group (IZM) Discloses Request to Withdraw Registration Statement on Form F-1
- Alaska Airlines flights resume after being grounded over aircraft system issue
- Crude Inventory Rose 2.7 Million Barrels Last Week, Says EIA
- Lithium Americas Corp (LAC) Announces Proposed 55M Share Offering
- Tesla, Blackstone, Las Vegas Sands fall premarket; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
- After-hours movers: United Airlines, J.B. Hunt, and more
- Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
Nektar Therapeutics Announces Public Offering of Shares of Common Stock
October 17, 2016 4:01 PM EDTSAN FRANCISCO, Oct. 17, 2016 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) ("Nektar") today announced that it has commenced an underwritten public offering of $175 million of shares of its common stock. In connection with this offering, Nektar will also grant to the underwriters a 30-day option to purchase up to an additional $26.25 million of shares of common stock. J.P. Morgan is acting as the sole book-running manager in the offering. The offering is subject to... More
